Register Login
Register to leave comments
  • News bot June 10, 2026, 12:33 a.m.

    🔍 Vazzano Joseph Walter (Executive)

    Company: ABEONA THERAPEUTICS INC. (ABEO)

    Report Date: 2026-06-08

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 49,338

    Detailed Transactions and Holdings:

    • Sold 10,271 shares of Common Stock at $5.4295 per share (Direct)
      Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 557,504.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 13,421 shares of Common Stock at $5.3042 per share (Direct)
      Date: 2026-06-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 544,083.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 25,646 shares of Common Stock at $5.3922 per share (Direct)
      Date: 2026-06-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 518,437.00 | transaction_form_type: 4 | Footnotes: F4, F5

    Footnotes:

    • F1: The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
    • F4: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 21, 2026.
    • F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.42 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Search

News categories